Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

136531 Press Releases
DateTitleCompany
26 Sep 16 Cancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell Capture and Detection Published by
GlobeNewswire
26 Sep 16 MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers Published by
GlobeNewswire
26 Sep 16 Myriad to Present New myRisk Hereditary Cancer Data Further Demonstrating the Benefits of Gene Panel Testing Published by
GlobeNewswire
26 Sep 16 Onconova Announces Successful End-of-Phase 2 Meeting with FDA for Oral Rigosertib and Azacitidine Combination Published by
GlobeNewswire
26 Sep 16 Lumenis Announces Participation in First Educational Course at the 17th European Burns Association Congress Published by
GlobeNewswire
26 Sep 16 Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metastatic Melanoma Published by
GlobeNewswire
26 Sep 16 Summit Receives Fast Track Designation From US FDA for Ezutromid in the Treatment of Duchenne Muscular Dystrophy Published by
GlobeNewswire
26 Sep 16 Versartis Initiates Phase 3 Trial of Somavaratan in Japan for Children with Growth Hormone Deficiency Following Completion of Phase 2 Published by
GlobeNewswire
26 Sep 16 Complete Response Letter for REMOXY® Published by
GlobeNewswire
26 Sep 16 Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant Published by
GlobeNewswire
26 Sep 16 GW Pharmaceuticals Announces Second Positive Phase 3 Pivotal Trial for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome Published by
GlobeNewswire
26 Sep 16 BioCryst Closes $23 Million Senior Credit Facility  Published by
GlobeNewswire
26 Sep 16 Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities Published by
GlobeNewswire
26 Sep 16 Vical Announces Initiation of a Phase 2 Trial of Its HSV-2 Therapeutic DNA Vaccine for Genital Herpes Published by
GlobeNewswire
26 Sep 16 Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer Published by
GlobeNewswire
26 Sep 16 Mateon Announces Collaboration with US Oncology Research to Participate in Phase 2/3 FOCUS Study Published by
GlobeNewswire
26 Sep 16 Aduro Biotech’s Stephen T. Isaacs Named 2016 Visionary Leader by Berkeley Chamber of Commerce Published by
GlobeNewswire
26 Sep 16 CoLucid Pharmaceuticals to Present at the Ladenburg Thalmann 2016 Healthcare Conference Published by
GlobeNewswire
26 Sep 16 Virtual Health Welcomes Cybersecurity Expert Dan Bart as Executive Vice President of Information Security and Implementation Virtual Health,
Published by
PR Newswire
26 Sep 16 Axovant Sciences Receives FDA Fast-Track Designation for Intepirdine as an Investigational Treatment for Dementia with Lewy Bodies Axovant Sciences Ltd.,
Published by
PR Newswire
26 Sep 16 Medtronic's StealthStation® Cranial Software Receives FDA Clearance as an Aid for Deep Brain Stimulation Lead Placement Medtronic plc,
Published by
GlobeNewswire
26 Sep 16 MD Anderson Cancer Center and Adaptimmune Form Strategic Alliance to Advance Development of Immunotherapies Targeting Multiple Cancers Adaptimmune Therapeutics plc,
Published by
GlobeNewswire
26 Sep 16 Summit Receives Fast Track Designation from US FDA for Ezutromid in the Treatment of DMD Summit Therapeutics plc,
Published by
GlobeNewswire
26 Sep 16 Idera Pharmaceuticals Reports Promising Data from Ongoing Phase 1 Dose Escalation in Clinical Trial of Intra-tumoral IMO-2125 in Combination with Ipilimumab in Patients with PD-1 Refractory Metasta... Idera Pharmaceuticals, Inc.,
Published by
GlobeNewswire
26 Sep 16 Lumenis Announces Participation in First Educational Course at the 17th European Burns Association Congress Lumenis Ltd.,
Published by
GlobeNewswire
26 Sep 16 Vericel to Present at 2016 Cell & Gene Meeting on the Mesa Published by
GlobeNewswire
26 Sep 16 Bioblast’s Special Medical Advisor to Make a Presentation Today On Trehalose as a Potential Therapeutic Agent for OPMD Published by
GlobeNewswire
26 Sep 16 BioSig Technologies Sponsors The 11th International Symposium on Ventricular Arrhythmias Published by
GlobeNewswire
26 Sep 16 Lipocine Announces Positive Top-Line Phase 2b Study Results for LPCN 1111, a Next Generation Oral Testosterone Replacement Therapy Published by
GlobeNewswire
26 Sep 16 Healthcare & Technology Innovators Convene in Washington, D.C. Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.